The Problems And Strategy In Development Of China's Small And Medium-sized Pharmaceutical Enterprises

China's accession to the WTO has brought opportunities and challenges to the development of small and medium-sized pharmaceutical companies. Faced with the competition pressure from famous foreign pharmaceutical enterprises and large domestic pharmaceutical enterprises, many problems have emerged along with the development of our country's small and medium-sized pharmaceutical enterprises. Overall, five aspects of the difficulties in the survival and development of China's small and medium-sized pharmaceutical enterprises perspective are as follows: lackness of funds and difficulties in financing; marketing strategy fell behind and rigorous supervision on the drug advertising; uncompetitive products and incapability of products development and innovation; the building of enterprise culture and human resource management needs to be improved; and small-scale but relative surplus production capacity.Through the investigation of the reasons that exist in small and medium-sized pharmaceutical enterprises, we raise measurements and advice as follows:1. Expanding financing channels to solve the financing problem;2. Creating an innovative marketing mode to enhance market competitiveness;3. Optimizing the product mix and adjusting product strategy;4. Building the enterprise culture and stepping up personnel training;5. Integrating resource advantages and seeking win-win cooperation.Against the problems in China's small and medium-sized pharmaceutical enterprises, this paper raised a lot of advice and strategies. We hope it will be helpful for their survival and development.